Aclaris Therapeutics Inc —— 季度财务数据 (NASDAQ:ACRS) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -8.94 M-13.06 M-9.99 M-10.93 M-13.13 M -47.11 M 投资活动产生的现金 -88.72 M19.12 M5.05 M13.83 M10.37 M 48.37 M 融资活动产生的现金 74.58 M-275 K-9 000-3.04 M-2.53 M -5.86 M 自由现金流 -8.94 M-13.93 M-10.01 M-10.96 M-13.15 M -48.06 M

新闻

Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains?

H.C. Wainwright维持Aclaris Therapeutics买入评级

Aclaris Therapeutics stock rating reiterated at Buy by H.C. Wainwright

Stifel因管线前景上调Aclaris Therapeutics目标价至3美元

Stifel raises Aclaris Therapeutics stock price target to $3 on pipeline

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Aclaris TherapeuticsQ4每股收益及营收逊于预期

Aclaris Therapeutics Inc earnings missed by $0.01, revenue fell short of estimates

Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates

Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates

Aclaris启动ATI-052治疗哮喘患者的1b期试验

Aclaris starts phase 1b trial of ATI-052 in asthma patients